Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinoic acid receptor responder 2 pseudogene 3 (RARRES2P3)
- Target
- RARRES2P3
- Molecular classification
- Other (processed pseudogene)
01
Overview
Retinoic acid receptor responder 2 pseudogene 3 (RARRES2P3) is classified as a processed pseudogene, meaning it originated from retrotransposition of mRNA rather than conventional gene duplication. Its sequence is similar to RARRES2, but evidence does not support that it codes for a protein or has established biological function. Like many human pseudogenes, RARRES2P3 may be transcribed; however, there is no documentation of it being involved in gene regulation, disease, or therapeutic mechanisms[5][2][1]. Pseudogenes overall can contribute to regulatory networks and sometimes impact disease, but RARRES2P3 specifically has not been implicated in such roles. No drugs or biomarkers are associated with this pseudogene, and it is not a valid therapeutic target. Misidentification or confusion with RARRES2 (Retinoic acid receptor responder 2) should be avoided, as only RARRES2 is functionally characterized and is associated with biological processes such as adipogenesis, inflammation, and metabolism[4].
- Other names
- Retinoic acid receptor responder (tazarotene induced) 2 pseudogene 3RARRES2P3
Beyond the preview
Go deeper on Retinoic acid receptor responder 2 pseudogene 3 (RARRES2P3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Retinoic acid receptor responder 2 pseudogene 3 (RARRES2P3).